Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers

Torben Steiniche, Morten Ladekarl, Jeanette Baehr Georgsen, Simon Andreasen, Michael Busch-Sorensen, Wei Zhou, Matthew J Marton, Scott K Pruitt, Fan Jin, Kai-Li Liaw

Research output: Contribution to journalJournal articleResearchpeer-review

25 Downloads (Pure)
Original languageEnglish
Article numberFSO616
JournalFuture Science OA
Volume6
Issue number8
Number of pages11
ISSN2056-5623
DOIs
Publication statusPublished - 19 Aug 2020

Bibliographical note

© 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.

Keywords

  • anal carcinoma
  • biliary adenocarcinoma
  • cervical carcinoma
  • endometrial carcinoma
  • mesothelioma
  • neuroendocrine tumors
  • salivary gland carcinoma
  • small-cell lung carcinoma
  • thyroid carcinoma
  • vulvar carcinoma

Fingerprint Dive into the research topics of 'Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers'. Together they form a unique fingerprint.

Cite this